These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16932514

  • 21. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C, Hartford J, Russell J, Ball S, Erickson J, Raskin J, Rynn M.
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Jun; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 23. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial: botulinum toxin for neuropathic pain?
    Torgovnick J, Arsura E, Sethi NK, Hu CJ, Yuan RY, Sheu JJ, Apfel SC.
    Neurology; 2010 Jan 05; 74(1):92; author reply 92-3. PubMed ID: 20038781
    [No Abstract] [Full Text] [Related]

  • 24. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
    Wohlreich MM, Watkin JG, Gonzales JS.
    J Clin Psychiatry; 2004 Jul 05; 65(7):1018-9. PubMed ID: 15291696
    [No Abstract] [Full Text] [Related]

  • 25. Dyskinesia during treatment with duloxetine.
    Deuschle M, Mase E, Zink M.
    Pharmacopsychiatry; 2006 Nov 05; 39(6):237-8. PubMed ID: 17124651
    [No Abstract] [Full Text] [Related]

  • 26. A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
    Llorca PM, Bodkin JA, Spann M, Ball SG, Russell JM, Ball SG.
    J Clin Psychopharmacol; 2009 Feb 05; 29(1):96-7. PubMed ID: 19142122
    [No Abstract] [Full Text] [Related]

  • 27. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
    Marchettini P, Wilhelm S, Petto H, Tesfaye S, Tölle T, Bouhassira D, Freynhagen R, Cruccu G, Lledó A, Choy E, Kosek E, Micó JA, Späth M, Skljarevski V, Lenox-Smith A, Perrot S.
    Eur J Pain; 2016 Mar 05; 20(3):472-82. PubMed ID: 26311228
    [Abstract] [Full Text] [Related]

  • 28. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.
    Ann Clin Psychiatry; 2008 Mar 05; 20(4):187-93. PubMed ID: 19034749
    [Abstract] [Full Text] [Related]

  • 29. Are opioids effective in the treatment of neuropathic pain?
    Guirguis-Blake J, Kelly C.
    Am Fam Physician; 2007 Apr 01; 75(7):999-1001. PubMed ID: 17427612
    [No Abstract] [Full Text] [Related]

  • 30. Treating diabetic peripheral neuropathic pain.
    Lindsay TJ, Rodgers BC, Savath V, Hettinger K.
    Am Fam Physician; 2010 Jul 15; 82(2):151-8. PubMed ID: 20642268
    [Abstract] [Full Text] [Related]

  • 31. [Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].
    Ziegler D.
    Dtsch Med Wochenschr; 2006 Dec 15; 131 Suppl 8():S284-8. PubMed ID: 17139588
    [Abstract] [Full Text] [Related]

  • 32. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH, Wilson MG, Kornstein SG, Clayton AH, Trivedi MH, Wohlreich MM, Fava M.
    Ann Clin Psychiatry; 2008 Dec 15; 20(4):209-18. PubMed ID: 19034753
    [Abstract] [Full Text] [Related]

  • 33. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
    Davidson JR, Wittchen HU, Llorca PM, Erickson J, Detke M, Ball SG, Russell JM.
    Eur Neuropsychopharmacol; 2008 Sep 15; 18(9):673-81. PubMed ID: 18559291
    [Abstract] [Full Text] [Related]

  • 34. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R.
    J Psychiatr Res; 2008 Oct 15; 42(12):1042-9. PubMed ID: 18221755
    [Abstract] [Full Text] [Related]

  • 35. Duloxetine status.
    Fishbain DA.
    Pain Med; 2007 Sep 15; 8 Suppl 2():S25-6. PubMed ID: 17714112
    [No Abstract] [Full Text] [Related]

  • 36. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
    Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H.
    Pain; 2009 Dec 15; 146(3):253-260. PubMed ID: 19625125
    [Abstract] [Full Text] [Related]

  • 37. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects.
    Sindrup SH.
    Dan Med Bull; 1994 Feb 15; 41(1):66-78. PubMed ID: 8187566
    [No Abstract] [Full Text] [Related]

  • 38. Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.
    Gupta R, Wu JJ, Levin E, Koo JY, Liao W.
    J Drugs Dermatol; 2013 Oct 15; 12(10):1089. PubMed ID: 24085041
    [No Abstract] [Full Text] [Related]

  • 39. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW, Deliyannides DA, McGrath PJ.
    Int Clin Psychopharmacol; 2008 Nov 15; 23(6):333-6. PubMed ID: 18854721
    [Abstract] [Full Text] [Related]

  • 40. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.